Skip to main content
SpringerLink
Log in

The international variation in breast cancer rates: An epidemiological assessment

  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Abstract

Part of the international differences in breast cancer incidence rates can be explained by geographic variation in reproductive and other breast cancer risk factors. Age at menarche and age at onset of regular ovulatory menstrual cycles are two such factors; both vary across populations directly according to breast cancer risk, and both are acknowledged as breast cancer risk factors. Consideration of the body of evidence on these factors, as well as that on age at menopause, suggests that the cumulative frequency of ovulatory menstrual cycles is a critical determinant of breast cancer risk. Although age at first term pregnancy explains the majority of the protective effect of parity on breast cancer risk, two recent studies have demonstrated a small residual protective effect of increasing number of births. It appears that pregnancy hasparadoxical effects on breast cancer risk in terms of hormone production and metabolism. The initial effect is an increased risk associated with first trimester estrogen exposure. However, the hormonal consequences of completing the pregnancy counteract this negative effect of early pregnancy. The effect of body weight, a breast cancer risk factor for postmenopausal women, can be explained in terms of increased extraglandular conversion of androstenedione to estrone. Further evidence supporting a pathogenic role of estrogens in the development of breast cancer comes from international studies of endogenous hormones in populations with differing risks of breast cancer. These risk factors have been incorporated into a mathematical model which is based on the concept that breast tissue ages according to hormonal (primarily estrogen) exposure; this model closely predicts the incidence rates throughout the world.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. WHO IARC: Cancer Incidence in Five Continents, vol 5. Muir C, Waterhouse J, Mack T,et al. (eds): Lyon, IARC Sci Publ 88, 1987, p 882

    Google Scholar 

  2. Haenszel W, Kurihara M: Studies of Japanese migrants. I. Mortality from cancer and other diseases among Japanese in the United States. J Natl Cancer Inst 40: 43–68, 1968

    PubMed  CAS  Google Scholar 

  3. Buell P: Changing incidence of breast cancer in Japanese-American women. J Natl Cancer Inst 51: 1479–1483, 1973

    PubMed  CAS  Google Scholar 

  4. Dunn J: Breast cancer among American Japanese in the San Francisco Bay area. Natl Cancer Inst Monogr 47: 157, 1977

    PubMed  Google Scholar 

  5. Henderson BE, Pike MC, Casagrande JT: Breast cancer and the estrogen window hypothesis. Lancet 2: 363–364, 1981

    Article  PubMed  CAS  Google Scholar 

  6. Henderson BE, Gerkins V, Rosario I, Casagrande JT, Pike MC: Elevated serum levels of estrogen and prolactin in daughters of patients with breast cancer. N Engl J Med 293: 790–795, 1975

    Article  PubMed  CAS  Google Scholar 

  7. Trichopoulos D, Brown JB, Garas J: Elevated urine estrogen and pregnanediol levels in daughters of breast cancer patients. J Natl Cancer Inst 67: 603–606, 1981

    PubMed  CAS  Google Scholar 

  8. Henderson BE, Ross RK, Judd HL, Krailo MD, Pike MC: Do regular ovulatory cycles increase breast cancer risk? Cancer 56: 1206–1208, 1985

    Article  PubMed  CAS  Google Scholar 

  9. MacMahon B, Trichopoulos D, Brown J, Anderson AP, Aoki K,et al.: Age at menarche, probability of ovulation and breast cancer risk. Int J Cancer 29: 13–16, 1982

    Article  PubMed  CAS  Google Scholar 

  10. Apter D, Vihko R: Early menarche, a risk factor for breast cancer, indicates early onset of ovulatory cycles. J Clin Endocrinol Metab 57: 82–86, 1983

    Article  PubMed  CAS  Google Scholar 

  11. Apter D, Reinila M, Vihko R: Some endocrine characteristics of early menarche, a risk factor for breast cancer, are preserved into adulthood. Int J Cancer 44: 783–787, 1989

    Article  PubMed  CAS  Google Scholar 

  12. Tanner JM: Growth at Adolescence. Blackwell Scientific, Oxford, 1962, pp 1–27

    Google Scholar 

  13. Frisch RE, McArthur J. Menstrual cycles: fatness as a determinant of minimum weight for height necessary for their maintenance or onset. Science 185: 949–951, 1974

    Article  PubMed  CAS  Google Scholar 

  14. Frisch RE, Gotz-Welbergen AV, McArthur JW, Albright T, Witschi J,et al: Delayed menarche and amenorrhea of college athletes in relation to age at onset of training. JAMA 246: 1559–1563, 1981

    Article  PubMed  CAS  Google Scholar 

  15. Bernstein L, Ross R, Lobo R, Hanisch R, Krailo MD, Henderson BE: The effects of moderate physical activity on menstrual cycle patterns in adolescence: Implications for breast cancer prevention. Br J Cancer 55: 681–685, 1987

    PubMed  CAS  Google Scholar 

  16. Trichopoulos D, MacMahon B, Cole P: The menopause and breast cancer risk. J Natl Cancer Inst 48: 605–613, 1972

    PubMed  CAS  Google Scholar 

  17. Feinleib M: Breast cancer and artificial menopause: A cohort study. J Natl Cancer Inst 41: 315–329, 1968

    PubMed  CAS  Google Scholar 

  18. MacMahon B, Cole P, Lin TM, Lowe CR, Mirra AP,et al.: Age at first birth and cancer of the breast. A summary of an international study. Bull WHO 43: 209–221, 1970

    PubMed  CAS  Google Scholar 

  19. Layde PM, Webster LA, Baughman AL, Wingo PA, Rubin GL, Ory HW: The independent associations of parity, age at first full term pregnancy, and duration of breastfeeding with the risk of breast cancer. Cancer and Steroid Hormone Study Group. J Clin Epidemiol 42: 963–973, 1989

    Article  PubMed  CAS  Google Scholar 

  20. Yuan JM, Yu MC, Ross RK, Gao YT, Henderson BE: Risk factors for breast cancer in Chinese women in Shanghai. Cancer Res 48: 1949–1953, 1988

    PubMed  CAS  Google Scholar 

  21. Bruzzi P, Negri E, La Vecchia C,et al.: Short term increase in risk of breast cancer after full term pregnancy. Br Med J 297: 1096–1098, 1988

    Article  CAS  Google Scholar 

  22. Pike MC, Henderson BE, Casagrande JT, Rosario I, Gray GE: Oral contraceptive use and early abortion as risk factors for breast cancer in young women. Br J Cancer 43: 72–76, 1981

    PubMed  CAS  Google Scholar 

  23. Hadjimichael OC, Boyle CA, Meigs JW: Abortion before first live birth and risk of breast cancer. Br J Cancer 53: 281–284, 1986

    PubMed  CAS  Google Scholar 

  24. Pike MC, Krailo MC, Henderson BE, Casagrande JT, Hoel DG: ‘Hormonal’ risk factors, ‘breast tissue age’ and the age-incidence of breast cancer. Nature 303: 767–770, 1983

    Article  PubMed  CAS  Google Scholar 

  25. Bernstein L, Depue RH, Ross RK, Judd HL, Pike MC, Henderson BE: Higher maternal levels of free estradiol in first compared to second pregnancy: Early gestational differences. J Natl Cancer Inst 76: 1035–1039, 1986

    PubMed  CAS  Google Scholar 

  26. Yu MC, Gerkins VR, Henderson BE, Brown JB, Pike MC: Elevated levels of prolactin in nulliparous women. Br J Cancer 43: 826–831, 1981

    PubMed  CAS  Google Scholar 

  27. Musey VC, Collins DC, Musey PI, Martino-Saltzman D, Preedy JR: Long-term effect of a first pregnancy on the secretion of prolactin. N Engl J Med 316: 229–234, 1987

    Article  PubMed  CAS  Google Scholar 

  28. Bernstein L, Pike MC, Ross RK, Judd HL, Brown JB, Henderson BE: Estrogen and sex hormone-binding globulin levels in nulliparous and parous women. J Natl Cancer Inst 74: 741–745, 1985

    PubMed  CAS  Google Scholar 

  29. de Waard F, Cornelis JP, Aoki K, Yoshida M: Breast cancer incidence according to weight and height in two cities of the Netherlands and in Aichi Prefecture, Japan. Cancer 40: 1269–1275, 1977

    Article  PubMed  Google Scholar 

  30. Siiteri PK, Hammond GL, Nisker JA: Increased availability of serum estrogens in breast cancer: A new hypothesis. In Pike MC, Siiteri PK, Welsch CW (eds) Hormones and Breast Cancer. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, 1981, p 87–101

    Google Scholar 

  31. Henderson BE, Ross RK, Bernstein L: Estrogens as a cause of human cancer: The Richard and Hinda Rosenthal Foundation Award Lecture. Cancer Res 48: 246–253, 1988

    PubMed  CAS  Google Scholar 

  32. MacMahon B, Cole P, Brown JB, Aoki K, Lin TM,et al.: Urine estrogen profiles of Asian and North American women. Int J Cancer 14: 161–167, 1974

    Article  PubMed  CAS  Google Scholar 

  33. Parkin DM, Stjernsward J, Muir CS: Estimates of the worldwide frequency of twelve major cancers. Bull WHO 62: 163–182, 1984

    PubMed  CAS  Google Scholar 

  34. Bruning PF, Bronfrer JMG, Hart AAM: Non-protein bound oestradiol, sex hormone binding globulin, breast cancer and breast cancer risk. Br J Cancer 51: 479–484, 1985

    PubMed  CAS  Google Scholar 

  35. Drafta D, Schindler AF, Milcu M, Keller E, Stroe E,et al.: Plasma hormones in pre- and postmenopausal breast cancer. J Steroid Biochem 13: 793–802, 1980

    Article  PubMed  CAS  Google Scholar 

  36. England PC, Skinner LG, Cottrell KM, Sellwood RA: Serum oestradiol-17β in women with benign and malignant breast disease. Br J Cancer 30: 571–576, 1974

    PubMed  CAS  Google Scholar 

  37. Malarkey WB, Schroeder LL, Stevens VC, James AG, Lanese RR: Twenty-four-hour preoperative endocrine profiles in women with benign and malignant breast disease. Cancer Res 37: 4655–4659, 1977

    PubMed  CAS  Google Scholar 

  38. Meyer F, Brown JB, Morrison AS, MacMahon B: Endogenous sex hormones, prolactin, and breast cancer in premenopausal women. J Natl Cancer Inst 77: 613–616, 1986

    PubMed  CAS  Google Scholar 

  39. Key TJA, Pike MC: The role of oestrogens and progestagens in the epidemiology and prevention of breast cancer. Eur J Cancer Clin Oncol 24: 29–43, 1988

    Article  PubMed  CAS  Google Scholar 

  40. Bernstein L, Yuan JM, Ross RK, Pike MC, Lobo R,et al.: Serum hormone levels in premenopausal Chinese women in Shanghai and white women in Los Angeles: results from two breast cancer case-control studies. (submitted)

  41. Shimizu H, Ross RK, Bernstein L, Pike MC, Henderson BE: Serum estrogen levels in postmenopausal women: comparison of US whites and Japanese in Japan. Br J Cancer (in press)

  42. Hoel DG, Wakabayashi T, Pike MC: Secular trends in the distribution of the breast cancer risk factors: Menarche, first birth, menopause and weight in Hiroshima and Nagasaki, Japan. Am J Epidemiol 118: 78–89, 1983

    PubMed  CAS  Google Scholar 

  43. Fujimoto I, Hanai A, Oshima A: Descriptive epidemiology of cancer in Japan: Current cancer incidence and survival data. NCI Monograph 53: 5–15, 1979

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Preventive Medicine, University of Southern California School of Medicine, Norris Cancer Hospital and Research Institute, 1441 Eastlake Avenue, 90033, Los Angeles, California, USA

    Brian E. Henderson & Leslie Bernstein

Authors
  1. Brian E. Henderson
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Leslie Bernstein
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Henderson, B.E., Bernstein, L. The international variation in breast cancer rates: An epidemiological assessment. Breast Cancer Res Tr 18 (Suppl 1), S11–S17 (1991). https://doi.org/10.1007/BF02633520

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02633520

Key words

Search

Navigation